Endi mavjud! Telegram Tadqiqoti 2025 — yilning asosiy insaytlari 
Hidden Multibagger Stocks by Devendra (RA: INH000026488)
Kanalga Telegram’da o‘tish
Disclaimer: I am a SEBI Registered Research Analyst (RA: INH000026488). All stocks, market updates, and investment-related information shared in this channel are strictly for educational and informational purposes only.
Ko'proq ko'rsatish9 877
Obunachilar
+824 soatlar
+267 kunlar
+6230 kunlar
Postlar arxiv
From January to September 2024, DII activity in the Pharma & Healthcare sector reveals key trends:👆👆
a. In large-cap stocks, DIIs bought approximately 14,000 crore but sold around 15,000 crore, resulting in a net sell or exit position.
b. In mid-cap stocks, DIIs invested about 14,000 crore and sold around 10,000 crore, indicating a net buy position—respectable, though not remarkable.
c. In small-cap stocks, DIIs invested close to 30,000 crore while selling only around 5,000 crore, showing strong support in this segment.
This data highlights that DIIs have directed more capital toward small-cap stocks in the pharma and healthcare sectors. This strategic emphasis on small caps has contributed significantly to the recent outperformance of our selected stocks, even as the broader market has seen a downturn, resulting in losses for many investors. Over the past three months, the pharma and healthcare sectors have consistently generated positive returns, while most other sectors have struggled. In a market where corrections are common, careful stock selection is essential.
Our approach to stock selection is based on analyzing current market conditions, and all of our chosen stocks in both free and premium channels over the past three months have shown strong performance, despite a continuously declining market. Notable outperformers include
Indraprastha Medical
Poly Medicure
RPG LifeSciences
Jubilant Pharmova
Innova Captab
Yatharth Hospital
Supriya Lifescience
Piramal Pharma.
" Yatharth hospital " posted good Q2 result...💥
" RPG LIFESCIENCES " Posted very good Q2 result...💥
( Profit is less as 32Cr one time payment given to MIDC)
" Insolation energy " posted outstanding Q2 result...
Non-stop FII selling continues, and today the market faced significant pressure as DIIs failed to absorb the FII outflows. The outcome of tonight's FED meeting will influence the direction of the US 10-year bond yield. FIIs have been pulling money from the Indian market as US bond yields have been on the rise since the beginning of October. When bond yields are high, funds typically shift from the stock market to the bond market.If the Fed signals a more rapid approach to interest rate cuts in the future, bond yields may decrease; otherwise, yields could continue rising. If bond yields reach 5%, we could see even larger FII outflows in the coming days.In this market, careful stock selection is crucial. Despite the market volatility, our selected stocks have performed exceptionally well. Even if some stocks decline due to broader market trends, they tend to rebound strongly as the market recovers. It’s essential to identify sectors and stocks poised to outperform in the future.
" Indraprastha Medical," a new multibagger stock has recovered strongly ..🚀🚀
Throughout the day, strong selling continued from FIIs. Tonight's outcome of the Federal Reserve meeting will determine whether the U.S. 10-year bond yield will rise or fall, which could impact FII flows in our market.
The market is expected to be highly volatile today ahead of the Fed meeting outcome, as FIIs continue their selling.
" Kellton tech " strong recovery.. Back to buy level..🚀🚀
" Jubilant Pharmova " New stock heading for breakout...🚀🚀
FII selling continued today, but DII buying managed to absorb much of it, with retail investors also stepping in significantly. The next 2-3 days are particularly crucial, as the FED upcoming interest rate decision will likely influence the U.S. bond market. If the U.S. bond yield nears 5%, we could see increased selling from FIIs in our market. Monitoring U.S. bond yields closely over the next few days is important, as a decrease in yields following the Fed meeting would be a positive indicator.
Additionally, China is expected to announce a large stimulus package in response to Trump’s policies, which have been particularly strict toward China. The pharma CDMO sector, which has already rallied over the past two months, stands to benefit from this potential stimulus. Today’s market pullback should not be mistaken for a recovery. Next week will be key for understanding the FII outlook on the Indian market. In this environment, careful stock selection is essential to avoid losses, even during market declines.
"One of our member shared that he faced significant losses in swing trading. In our channel, however, we prioritize quality over quantity and accuracy over simply providing a long list of stocks. Unlike other channels in India, we don’t set stop-loss levels for swing trades because the stocks we select have minimal downside risk and high upside potential."
" Supriya Lifescience " Non stop rally continue..💃💃
" Updater services ltd " New stock has given breakout...🚀🚀
" Tejas Network " Strong breakout ..company has posted outstanding Q2 result..💃💃🚀🚀
Donald Trump has won the U.S. presidential election, which aligns with market expectations of his victory. Today, it seems that FIIs have been buyers in the Indian market, breaking their pattern of continuous selling over the past month. With this election result, one major event is behind us. Tomorrow, we’ll have the outcome of the Fed meeting, followed by the anticipated China stimulus package — two critical upcoming events.
After the Fed meeting, attention will shift to the U.S. 10-year bond yield, currently at 4.4%. If the bond yield continues to rise, it could prompt FIIs to pull money out of emerging markets. By next week, based on these developments, we should have a clearer picture of whether FIIs will return to the Indian market.
